Mr. Pat Donnelly

• 
  www.medgenesis.com/board_of_directors.htm - [Cached Version]
  Published on: 11/13/2008    Last Visited: 11/13/2008  

  Patrick (Pat) K. Donnelly Former President & CEO, PRA International
  
  Mr. Donnelly is the former President & CEO, and Board Member of PRA International (NASDAQ: PRAI). Having joined the company in 1994, he was instrumental in directing PRA's dramatic growth from a small regional contract research organization to one of the top global players in the industry with over $335 million in revenue. During his tenure as Chief Financial Officer and Chief Operating Officer, then as President, and in 2002 as CEO, he executed and integrated thirteen strategic international acquisitions as well as lead the company through its IPO in 2004, and subsequent successful secondary offering in 2005 both raising over $275 million and stock appreciation of 50% since the IPO. In 2006, PRA International was named to Forbes' Top 200 Best Small Companies and in 2005 it was ranked 55th in BusinessWeek's Top 100 Growth Companies. Prior to his tenure at PRA, he was President of Virginia Capital, L.P. and Vedcorp, LLC, two affiliated venture capital firms. He also spent eight years with BancBoston Capital. Mr. Donnelly graduated from The Pennsylvania State University with a MBA in 1984 and a BS from the University of Missouri in 1980.

• 
  www.sec.gov/Archives/edgar/data/1293243/0001209191-06-0 - [Cached Version]
  Published on: 11/20/2006    Last Visited: 11/22/2006  

  0001296793 Donnelly Patrick K C/O PRA INTERNATIONAL 12120 SUNSET HILLS ROAD, SUITE 600 RESTON VA 20190 1 1 0 0 President and CEO

• 
  www.pharmpro.com/ShowPR~PUBCODE~021~ACCT~0000100~ISSUE~ - [Cached Version]
  Published on: 7/15/2008    Last Visited: 7/15/2008  

  As part of the recapitalization, Trio becomes the first participating company in a series of strategic acquisitions by a partnership between Halifax, SV Life Sciences and an experienced management team led by Pat Donnelly.Mr. Donnelly most recently served as chief executive officer and president of PRA International and has more than 14 years of experience in the CRO industry.Donnelly was instrumental in directing PRA's dramatic growth from a small regional contract research organization to one of the top global service providers in the industry.While at PRA he executed and integrated thirteen strategic international acquisitions and also led the company through its IPO in 2004 and secondary offering in 2005.
  
  "I am very excited to be joining such an experienced and successful executive management team as the one built by Mss.Woolf and Brown.Their dedication to quality and flexibility in the clinical research industry is second-to-none," said Mr. Donnelly.

• 
  dc.citybizlist.com/lstg/lstgDetail.aspx?id=37981 - [Cached Version]
  Published on: 7/29/2008    Last Visited: 9/15/2008  

  As part of the recapitalization, Trio becomes the first participating company in a series of strategic acquisitions by a partnership between Halifax, SV Life Sciences and an experienced management team led by Pat Donnelly, former chief executive officer of PRA International.

• 
  www.clinicaltrialstoday.com/personnel/index.html - [Cached Version]
  Published on: 9/24/2008    Last Visited: 9/25/2008  

  Patrick Donnelly Resigns From PRA
  ...
  PRA International announced the resignation of the company's president and chief executive officer, Patrick Donnelly.He will work as a consultant for 18 months and will receive $2,000 for each day as a consultant.PRA went public, acquired 10 companies and increased its global operations during the past 13 years under Donnelly as CEO.
  
  The company will pay the former executive a severance of $1 million.PRA has hired a global executive recruitment firm to find a permanent replacement for Donnelly.
  ...
  "After 13 rewarding years with PRA I have made the decision to leave the company to embrace new challenges and opportunities," said Donnelly.

• 
  www.clinicaltrialstoday.com/2006/12/patrick_donnell.htm - [Cached Version]
  Published on: 1/1/2006    Last Visited: 9/25/2008  

  Patrick Donnelly Resigns From PRA
  ...
  PRA International announced the resignation of the company's president and chief executive officer, Patrick Donnelly.He will work as a consultant for 18 months and will receive $2,000 for each day as a consultant.PRA went public, acquired 10 companies and increased its global operations during the past 13 years under Donnelly as CEO.
  
  The company will pay the former executive a severance of $1 million.PRA has hired a global executive recruitment firm to find a permanent replacement for Donnelly.
  ...
  "After 13 rewarding years with PRA I have made the decision to leave the company to embrace new challenges and opportunities," said Donnelly.

• 
  albany.bizjournals.com/washington/stories/2007/05/07/da - [Cached Version]
  Published on: 5/8/2007    Last Visited: 5/9/2007  

  Axia Medical, Invitrogen, Pharmaceutical Product Development, PRA International, Transfusion Technologies, Pat Donnelly, Mel Booth, Terry Bieker, Colin Shannon,
  ...
  PRA hired Bieker when Pat Donnelly resigned late last year.
  ...
  Donnelly, who served as president and CEO, had been with PRA for 13 years and guided the business through its IPO (NASDAQ: PRAI).

• 
  washington.bizjournals.com/washington/stories/2007/05/0 - [Cached Version]
  Published on: 5/8/2007    Last Visited: 5/8/2007  

  Axia Medical, Invitrogen, Pharmaceutical Product Development, PRA International, Transfusion Technologies, Pat Donnelly, Mel Booth, Colin Shannon, Terry Bieker,
  ...
  PRA hired Bieker when Pat Donnelly resigned late last year.
  ...
  Donnelly, who served as president and CEO, had been with PRA for 13 years and guided the business through its IPO (NASDAQ: PRAI).

• 
  phx.corporate-ir.net/phoenix.zhtml?c=180892&p=irol-news - [Cached Version]
  Published on: 6/6/2006    Last Visited: 11/6/2007  

  RESTON, Va., June 6, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- PRA International (Nasdaq: PRAI), a leading clinical research organization, today announced that Patrick Donnelly, PRA's President and CEO, will make a presentation to investors and financial analysts during the Goldman Sachs Twenty-Seventh Global Healthcare Conference in Dana Point, Calif.

• 
  www.vabio.org/news/VaBIO%20E-News%20May%2028%202004%20E - [Cached Version]
  Published on: 5/1/2004    Last Visited: 5/19/2005  

  "This is a momentous occasion for PRA as we break ground for a new home for our Kansas City operations, one of PRA's largest and fastest growing business units," said President and CEO Pat Donnelly.

Page:  1 2 3 4 5